This phase I trial is evaluating the safety and effectiveness of a new biological drug (CS1003) in patients with advanced cancers.
This trial is treating patients with advanced cancers (excluding blood cancers and cancers that have spread to the brain).
This is a systemic therapy trial .
You may be able to join this trial if:
- Your cancer has spread to other parts of the body.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
- You have been diagnosed with a prior or secondary type of cancer.
- You have had certain treatments, surgical procedures or drugs.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.